Alexandre Ribeiro

[Alexandre Ribeiro @alexandrearpr]

@houmanhemmati The FDA needs to be led by someone who thinks exactly like this — or at least as close to this as possible. FDA need you. @POTUS @POTUS45

[Alexandre Ribeiro @alexandrearpr]

@houmanhemmati 👏🏽👏🏽👏🏽👏🏽👏🏽👍🏽👍🏽👍🏽👍🏽

[Alexandre Ribeiro @alexandrearpr]

@houmanhemmati This is exactly the mindset patients with serious and rare diseases need at the FDA. Risk-benefit matters, but so does the risk of doing nothing while patients decline. @MAHA_Action @POTUS45

[Alexandre Ribeiro @alexandrearpr]

@houmanhemmati @RxRegA This is exactly the kind of thinking the FDA needs. Simple, understandable explanations and a truly patient-centered approach would build trust instead of confusion. These ideas are excellent and this is the mindset needed in FDA leadership @POTUS45

[Alexandre Ribeiro @alexandrearpr]

@houmanhemmati @Elijahjstacy Patients with rare diseases need this kind of thinking at CBER. not demanding “perfect” drugs, but ensuring safety and efficacy while preserving choice. That balance gives families, physicians, and patients with few options real hope. @DrMakaryFDA

[Alexandre Ribeiro @alexandrearpr]

@houmanhemmati @foxnewsnight Dr. Hemmati clearly has political views, as we all do. But what stands out is his ability to separate politics from healthcare. To him, patients are not red or blue they are people who need care. That mindset is exactly what healthcare leadership needs.

[Alexandre Ribeiro @alexandrearpr]

@ZM2514 @Elijahjstacy @docrodwong ??????

[Alexandre Ribeiro @alexandrearpr]

@MartinShkreli kkkkkkkkkkkkkkkkkkkkkkk perdeu perdeu

[Alexandre Ribeiro @alexandrearpr]

@biomeafusion Interesting, but investors are still waiting for the long-promised mechanistic biomarker data (C-peptide, HOMA-B) from COVALENT-111. Transparency matters.

[Craque Neto @10neto]

Vale lembrar que o Tricolor foi prejudicado, viu? O segundo gol do Cruzeiro foi irregular.